Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol

Keyphrases

• Clinical Outcomes 100%
• Mobility Assessment 100%
• D Study 100%
• Digital Mobility 100%
• Clinical Cohort 66%
• Health Technology Assessment 66%
• Impaired Mobility 66%
• Digital Mobility Outcomes 66%
• Regulatory Technology 66%
• Multiple Sclerosis 33%
• Patient Demographics 33%
• Clinical Validity 33%
• Osteoporosis 33%
• Physical Measures 33%
• Daily Living 33%
• Disability 33%
• Parkinson's Disease 33%
• Mobility Problems 33%
• Optimal Strategy 33%
• Age-related Illnesses 33%
• Chronic Disease 33%
• Cultural Representation 33%
• Validation Studies 33%
• Health Technology 33%
• Evidence-based 33%
• Outcome-based 33%
• Longitudinal Observational Study 33%
• Longitudinal Data 33%
• Disease Groups 33%
• Method Design 33%
• Care Needs 33%
• Frailty 33%
• Mobility Management 33%
• Mobility Impairment 33%
• Disease-modifying Therapy 33%
• Efficient Access 33%
• Regulatory Agencies 33%
• Personalized Care 33%
• Neurodegenerative Conditions 33%
• Clinical Validation 33%
• Respiratory Disease 33%
• Chronic Disease Management 33%
• Chronic Obstructive Pulmonary Disease 33%
• New Intervention 33%
• Neuroinflammatory Disorders 33%
• Disease Impact 33%
• Wearable Devices 33%
• Clinical Site 33%
• Proximal Femoral Fracture 33%
• Fall-related Injuries 33%
• Sarcopenia 33%
• Clinician-reported Outcomes 33%
• Physical Capacity 33%
• Subject Characteristics 33%
• Digital Health Technology 33%
• Body Sensors 33%
• Digital Outcomes 33%
• Innovative Medicines Initiative 33%
• Mobility Capacity 33%
• Geographical Representation 33%
• Performance-based Outcomes 33%
• Technological Agency 33%
• Age Representation 33%

Medicine and Dentistry

• Health Technology 100%
• Disease 50%
• Technology Assessment 50%
• Health Care Cost 25%
• Medicine 25%
• Parkinson's Disease 25%
• Clinical Finding 25%
• Clinician 25%
• Injury 25%
• Multiple Sclerosis 25%
• Chronic Disease 25%
• Osteoporosis 25%
• Inflammatory Disorder 25%
• Frailty 25%
• Patient Population 25%
• Cohort Study 25%
• Femur Fracture 25%
• Chronic Obstructive Pulmonary Disease 25%
• Respiratory Disease 25%
• Physical Capacity 25%
• Walking Difficulty 25%
• Wearable Sensor 25%
• Sarcopenia 25%
• Digital Health 25%